Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Koken Ltd. (7963.T)
Tokyo, JP
Koken Ltd., along with its subsidiaries, specializes in the production and sale of personal protective equipment for occupational use and products designed to enhance environmental quality throughout Japan. The company organizes its diverse operations into three primary divisions: Mask-Related Business, Environmental-Related Businesses, and Other Businesses. Koken provides advanced clean air solutions such as KOACH, a system for creating pristine zones; KOKENLAMINAR, a push-pull ventilation technology; and LAMIKOACH, an air ventilation system specifically engineered for contamination source control. Its offerings also include IMADEZE, a copper-based lactate antibacterial agent, and a variety of masks for both medical facilities and the general public. Furthermore, Koken supplies sophisticated functional water production systems, encompassing electrolyzed water generators, endoscope washers/disinfectors, blood stain washer kits, portable showers, and magnetically treated water. For industrial safety, the company manufactures a comprehensive range of respirators, including particulate, powered air-purifying, supplied air, chemical cartridge, and gas masks. It also offers respirators for general consumers, equipment vital for accident and disaster preparedness, and other protective gear like clothing, ear plugs, and face shields. Koken Ltd. was established in 1943 and is headquartered in Tokyo, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.42% | +5.76% | +3.73% | +2.64% | +5.53% | +5.47% | +18.08% | +20.12% | +4.01% | +26.45% | +289.20% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Devices: +11.2%+10.2% Q1'26: -0.4% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%+23.1% Q1'26: -44.2% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-2.1% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%+10.7% ★ Q1'26: +8.8% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%+5.5% ★ Q1'26: +4.6% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%-0.4% ★ Q1'26: -1.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×3.43× Q1'26: 2.43× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-01 | A | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hideaki Ibata | MD & Director | — | male |
| Hiroyuki Sakai | Advisor & Director | — | male |
| Mitsuji Muramatsu | Senior MD of Marketing Headquarters & Director | — | male |
| Nobuya Horiguchi | Executive Vice President of Manufacturing Division & Representative Director | — | male |
| Toshiaki Nagasaka | Director of Accounting Department, GM of Accounting Department & Director | — | male |
| Tsutomu Murakawa | President & Representative Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 7963.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
